|
|
||||||||
From The Rockefeller Institute, New York, New York
Abstract
It is established that M protein is the cellular component of group A streptococci responsible for the production of type-specific antibodies, which are the basis of type-specific immunity in man. Strains freshly isolated from acute infections, so far as is known at present, always contain M antigen.
Although many cultures containing M protein are avirulent for mice, all highly mouse-virulent group A strains contain M antigen. The amount of M protein in some cultures can be increased by serial mouse passage, and the virulence of such strains is usually increased at the same time. It is possible that the hyaluronic acid capsule in addition to M protein may be a factor in virulence, but its importance has not been clearly defined. M protein probably enhances virulence by impeding phagocytosis, and the capsule may contribute to virulence by a mechanism not yet fully elucidated.
So far no completely purified preparations of M protein have been obtained, but progress in this direction is being made. Once this is achieved, it may be possible to define the properties of this important antigen more accurately.
Footnotes
1 Presidential Address to the American Association of Immunologists, April 16, 1962.
This article has been cited by other articles:
![]() |
J. M. Budzik, L. A. Marraffini, P. Souda, J. P. Whitelegge, K. F. Faull, and O. Schneewind Amide bonds assemble pili on the surface of bacilli PNAS, July 22, 2008; 105(29): 10215 - 10220. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Dinkla, D. P. Nitsche-Schmitz, V. Barroso, S. Reissmann, H. M. Johansson, I.-M. Frick, M. Rohde, and G. S. Chhatwal Identification of a Streptococcal Octapeptide Motif Involved in Acute Rheumatic Fever J. Biol. Chem., June 29, 2007; 282(26): 18686 - 18693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Clements, D. Tull, A. W. Jenney, J. L. Farn, S.-H. Kim, R. E. Bishop, J. B. McPhee, R. E. W. Hancock, E. L. Hartland, M. J. Pearse, et al. Secondary Acylation of Klebsiella pneumoniae Lipopolysaccharide Contributes to Sensitivity to Antibacterial Peptides J. Biol. Chem., May 25, 2007; 282(21): 15569 - 15577. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neal, B. Beall, K. Ekelund, B. Henriques-Normark, A. Jasir, D. Johnson, E. Kaplan, M. Lovgren, R. R. Reinert, Members of the Strep-EURO Study Group and Internat, et al. International Quality Assurance Study for Characterization of Streptococcus pyogenes J. Clin. Microbiol., April 1, 2007; 45(4): 1175 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Siljander, M. Toropainen, A. Muotiala, N. P. Hoe, J. M. Musser, and J. Vuopio-Varkila emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1701 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. K. Stranger-Jones, T. Bae, and O. Schneewind Vaccine assembly from surface proteins of Staphylococcus aureus PNAS, November 7, 2006; 103(45): 16942 - 16947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kotloff, M. Corretti, K. Palmer, J. D. Campbell, M. A. Reddish, M. C. Hu, S. S. Wasserman, and J. B. Dale Safety and Immunogenicity of a Recombinant Multivalent Group A Streptococcal Vaccine in Healthy Adults: Phase 1 Trial JAMA, August 11, 2004; 292(6): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pichichero Explanations and Therapies for Penicillin Failure in Streptococcal Pharyngitis Clinical Pediatrics, November 1, 1992; 31(11): 642 - 649. [Abstract] [PDF] |
||||
![]() |
V. Fischetti, W. Hodges, and D. Hruby Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant Science, June 23, 1989; 244(4911): 1487 - 1490. [Abstract] [PDF] |
||||
![]() |
J. Spanier, S. Jones, and P Cleary Small DNA deletions creating avirulence in Streptococcus pyogenes Science, August 31, 1984; 225(4665): 935 - 938. [Abstract] [PDF] |
||||
![]() |
Scott JR and V. Fischetti Expression of streptococcal M protein in Escherichia coli Science, August 19, 1983; 221(4612): 758 - 760. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |